Abstract:The transformative integration of Machine Learning (ML) for Artificial General Intelligence (AGI)-enhanced clinical imaging diagnostics, is itself in development. In brain tumor pathologies, magnetic resonance imaging (MRI) is a critical step that impacts the decision for invasive surgery, yet expert MRI tumor typing is inconsistent and misdiagnosis can reach levels as high as 85%. Current state-of-the-art (SOTA) ML brain tumor models struggle with data overfitting and susceptibility to shortcut learning, further exacerbated in large-sized models with many tunable parameters. In a comparison with multiple SOTA models, our deep ML brain tumor diagnostics model, SIENNA, surpassed limitations in four key areas of prioritized minimal data preprocessing, an optimized architecture that reduces shortcut learning and overfitting, integrated inductive cross-validation method for generalizability, and smaller neural architecture. SIENNA is applicable across MRI machines and 1.5 and 3.0 Tesla, and achieves high average accuracies on clinical DICOM MRI data across three-way classification: 92% (non-tumor), 91% (GBM), and 93% (MET) with retained high F1 and AUROC values for limited false positives/negatives. SIENNA is a lightweight clinical-ready AGI framework compatible with future multimodal expanded data integration.

What problem does this paper attempt to address?

The paper aims to address several key issues in brain tumor diagnosis, particularly the challenges faced when using Magnetic Resonance Imaging (MRI) for diagnosis. Specifically, the research team developed a lightweight, general-purpose machine learning platform called SIENNA to improve the accuracy of brain tumor diagnosis. The main issues mentioned in the paper include: 1. **Consistency issues in MRI diagnosis**: There is inconsistency in experts' judgments based on MRI for brain tumor types, with a misdiagnosis rate as high as 85%. 2. **Problems with existing machine learning models**: Current state-of-the-art (SOTA) machine learning models face issues of overfitting and shortcut learning when handling brain tumor diagnosis data. Large models are particularly prone to these problems. 3. **Challenges in data preprocessing**: Over-preprocessing of public datasets (such as the BraTS dataset) limits the generalization ability of models, making it difficult for these models to adapt to real-world clinical data. 4. **Insufficient model generalization**: Existing models perform poorly when faced with new patients or unseen data. Especially under traditional cross-validation methods, these models may encounter images from the same patient, which does not align with clinical reality. To address the above issues, the research team proposed the SIENNA platform, which has the following features: - **Minimal preprocessing**: SIENNA employs minimal data preprocessing steps to retain the key features of the original MRI DICOM data. - **Optimized architecture design**: The platform's design reduces the risk of shortcut learning and overfitting, and it can better generalize to new data. - **Inductive cross-validation method**: A specific cross-validation strategy is used to evaluate the model's performance when faced with new patient data. - **Small neural networks**: SIENNA uses smaller neural network structures, which helps improve the model's generalization ability. With these improvements, SIENNA achieved high average accuracy in three classification tasks: non-tumor (92%), glioblastoma (GBM) (91%), and metastatic tumor (MET) (93%), and also performed well on other performance metrics such as F1 score and AUROC value. Additionally, SIENNA has been shown to be more generalizable than other SOTA models trained on highly preprocessed datasets.

SIENNA: Lightweight Generalizable Machine Learning Platform for Brain Tumor Diagnostics

Computational Intelligence Approach to Improve the Classification Accuracy of Brain Neoplasm in MRI Data

Refining neural network algorithms for accurate brain tumor classification in MRI imagery

Diversified AI Techniques for Augmenting Brain Tumor Diagnosis

Utilizing Deep Learning to Improve Diagnostic Accuracy in Glioma, Pituitary Tumors, and Meningiomas

SKIPNet: Spatial Attention Skip Connections for Enhanced Brain Tumor Classification

Innv-02. Brainmets: A Clinician-Friendly Software To Manually Segment Brain Metastases And Detect Primary Tumor Origin Using Deep Learning

An attention-guided convolutional neural network for automated classification of brain tumor from MRI

Clinical Applications of Artificial Intelligence, Machine Learning, and Deep Learning in the Imaging of Gliomas: A Systematic Review

Non-invasive classification of IDH mutation status of gliomas from multi-modal MRI using a 3D convolutional neural network

Deep learning-based end-to-end scan-type classification, pre-processing, and segmentation of clinical neuro-oncology studies

Deep Radiomics for Brain Tumor Detection and Classification from Multi-Sequence MRI

Convolutional Neural Networks for Glioma Segmentation and Prognosis: A Systematic Review

Role of Ensemble Deep Learning for Brain Tumor Classification in Multiple Magnetic Resonance Imaging Sequence Data

Advancing multi-categorization and segmentation in brain tumors using novel efficient deep learning approaches

An XAI-enhanced efficientNetB0 framework for precision brain tumor detection in MRI imaging

Efficient brain tumor grade classification using ensemble deep learning models

Machine Learning Applications for Differentiation of Glioma from Brain Metastasis—A Systematic Review

Deep semi-supervised learning for brain tumor classification

Evaluating the clinical applicability of neural networks for meningioma tumor segmentation on 3D MRI

Developing an Artificial Intelligence Model for Tumor Grading and Classification, Based on MRI Sequences of Human Brain Gliomas